Trial · NCT07895537
Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced Glaucoma: A Prospective Interventional Study
NCT07895537, Not applicable, Completed, Minia University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced Glaucoma: A Prospective Interventional Study. Trials, record NCT07895537. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895537
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced Glaucoma: A Prospective Interventional Study
- NCT number
- NCT07895537
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 16 participants, actual
- Lead sponsor
- Minia University
- Conditions
- Deep Sclerectomy With Trabeculotomy in Advanced Glaucoma
- Interventions
- Combined Deep Sclerectomy with Trabeculotomy
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Intraocular Pressure from Baseline to 3 Months After Surger | Baseline (preoperative) to 3 months after surger | he change in intraocular pressure (IOP), measured in mmHg using Goldmann applanation tonometry, from the preoperative baseline measurement to 3 months after combined deep sclerectomy with trabeculotomy and sub-flap mattress suture. The change will be calculated as the 3-month postoperative IOP minus the baseline IOP. |
| Secondary | Change in Antiglaucoma Medication Requirements | Baseline to 1, 3, and 6 months after surgery. | Change in the number of antiglaucoma medications used by participants from the preoperative baseline to postoperative follow-up visits. |
| Secondary | Percentage Reduction in Intraocular Pressure | Baseline to 1, 3, and 6 months after surgery.. | Percentage reduction in intraocular pressure (IOP) from baseline, calculated as \[(baseline IOP - postoperative IOP) / baseline IOP\] × 100. |
| Secondary | Percentage Reduction in Intraocular Pressure | Baseline to 1, 3, and 6 months after surgery. | Percentage reduction in intraocular pressure (IOP) from baseline, calculated as \[(baseline IOP - postoperative IOP) / baseline IOP\] × 100. |
| Secondary | Proportion of Eyes Achieving Complete and Qualified Surgical Success | 3 and 6 months after surgery. | The proportion of eyes meeting the predefined criteria for complete and qualified surgical success. Complete success is defined as IOP within the prespecified target range without antiglaucoma medications or additional glaucoma surgery. Qualified success is defined as IOP within the prespecified target range with or without antiglaucoma medications and without additional glaucoma surgery. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895537
GET https://conductscience.org/api/trials/v1/NCT07895537/registered